Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

FASN-IN-5

Inquiry
Cat. No.: OB0425LY-149
Synonyms: 1309805-49-9; Methanone, [(3S)-3-[[2-[4-(5-benzofuranyl)phenyl]-1H-imidazo[4,5-c]pyridin-1-yl]methyl]-1-pyrrolidinyl]cyclopropyl-; [(3S)-3-[[2-[4-(1-Benzofuran-5-yl)phenyl]imidazo[4,5-c]pyridin-1-yl]methyl]pyrrolidin-1-yl]-cyclopropylmethanone; 2-[4-(1-Benzo furan-5-yl)phenyl]-1-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl}-1H-imidazo[4,5-c]pyridine
Size: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.: 1309805-49-9
Compound CID: 57519543
FASN-IN-5

Specification

Description: FASN-IN-5 is a specific inhibitor of fatty acid synthase (FAS) with potential anti-tumor and anti-obesity effects.
Formula Weight: 462.54
Applications: FASN-IN-5 can be used to study obesity-related cancer cell metabolism and the role of FAS in obesity tumor biology.
Storage: Storage at -20°C.
Formula: C29H26N4O2
Specification: Enantiomeric excess: 98.97%
Appearance: Solid
Purity: 99.81%, determined by HPLC.
Solubility: DMSO
Pathway: Metabolic enzyme/Protease
Identity: Confirmed by NMR and LC-MS.
Target: Fatty acid synthase (FASN)

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.